Rhea M Shields
Examiner (ID: 2487, Phone: (571)272-3848 , Office: P/2915 )
Most Active Art Unit | 2915 |
Art Unit(s) | 2915 |
Total Applications | 3243 |
Issued Applications | 2995 |
Pending Applications | 31 |
Abandoned Applications | 206 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9575266
[patent_doc_number] => 08765680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Method for administering omega-conopeptide'
[patent_app_type] => utility
[patent_app_number] => 14/133303
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9676
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14133303
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/133303 | Method for administering omega-conopeptide | Dec 17, 2013 | Issued |
Array
(
[id] => 9762299
[patent_doc_number] => 08846622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Targeted delivery of botulinum toxin to the sphenopalatine ganglion'
[patent_app_type] => utility
[patent_app_number] => 13/967500
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8108
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967500 | Targeted delivery of botulinum toxin to the sphenopalatine ganglion | Aug 14, 2013 | Issued |
Array
(
[id] => 9318756
[patent_doc_number] => 20140051093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/952484
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 30013
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952484
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952484 | High level expression of recombinant toxin proteins | Jul 25, 2013 | Issued |
Array
(
[id] => 9455233
[patent_doc_number] => 08716241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'ApoIII and the treatment and diagnosis of diabetes'
[patent_app_type] => utility
[patent_app_number] => 13/935825
[patent_app_country] => US
[patent_app_date] => 2013-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7671
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935825
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935825 | ApoIII and the treatment and diagnosis of diabetes | Jul 4, 2013 | Issued |
Array
(
[id] => 9778150
[patent_doc_number] => 08853357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'High purity lipopeptides'
[patent_app_type] => utility
[patent_app_number] => 13/918083
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 20627
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/918083 | High purity lipopeptides | Jun 13, 2013 | Issued |
Array
(
[id] => 8977278
[patent_doc_number] => 20130210708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'METHODS OF INHIBITING AND TREATING BACTERIAL BIOFILMS BY METAL CHELATORS'
[patent_app_type] => utility
[patent_app_number] => 13/706042
[patent_app_country] => US
[patent_app_date] => 2013-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7890
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13706042
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/706042 | METHODS OF INHIBITING AND TREATING BACTERIAL BIOFILMS BY METAL CHELATORS | Apr 22, 2013 | Abandoned |
Array
(
[id] => 9094305
[patent_doc_number] => 20130273616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'POLYPEPTIDES AND BIOSYNTHETIC PATHWAYS FOR THE PRODUCTION OF MONATIN AND ITS PRECURSORS'
[patent_app_type] => utility
[patent_app_number] => 13/861973
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 45690
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13861973
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/861973 | POLYPEPTIDES AND BIOSYNTHETIC PATHWAYS FOR THE PRODUCTION OF MONATIN AND ITS PRECURSORS | Apr 11, 2013 | Abandoned |
Array
(
[id] => 9094312
[patent_doc_number] => 20130273622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Methods for the Economical Production of Biofuel from Biomass'
[patent_app_type] => utility
[patent_app_number] => 13/859903
[patent_app_country] => US
[patent_app_date] => 2013-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 64468
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859903
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/859903 | Methods for the economical production of biofuel from biomass | Apr 9, 2013 | Issued |
Array
(
[id] => 10856950
[patent_doc_number] => 08883143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Treatment of traumatic-induced migraine headache'
[patent_app_type] => utility
[patent_app_number] => 13/986197
[patent_app_country] => US
[patent_app_date] => 2013-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3209
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13986197
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/986197 | Treatment of traumatic-induced migraine headache | Apr 9, 2013 | Issued |
Array
(
[id] => 9363715
[patent_doc_number] => 20140073588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'GLUE COMPOSITION FOR LUNG VOLUME REDUCTION'
[patent_app_type] => utility
[patent_app_number] => 13/855596
[patent_app_country] => US
[patent_app_date] => 2013-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27151
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855596
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/855596 | GLUE COMPOSITION FOR LUNG VOLUME REDUCTION | Apr 1, 2013 | Abandoned |
Array
(
[id] => 9041695
[patent_doc_number] => 20130244333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'BIOLOGICAL MARKERS FOR LONGEVITY AND DISEASES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/832832
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 33817
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13832832
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/832832 | Biological markers for longevity and diseases and uses thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 9004374
[patent_doc_number] => 20130225499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'METHOD FOR ADMINISTERING OMEGA-CONOPEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 13/791715
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9644
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13791715
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/791715 | Method for administering omega-conopeptide | Mar 7, 2013 | Issued |
Array
(
[id] => 8904213
[patent_doc_number] => 20130171716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'ANIMAL PRODUCT FREE SYSTEM AND PROCESS FOR PURIFYING A BOTULINUM TOXIN'
[patent_app_type] => utility
[patent_app_number] => 13/781126
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 25208
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13781126
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/781126 | Animal product free system and process for purifying a botulinum toxin | Feb 27, 2013 | Issued |
Array
(
[id] => 9524130
[patent_doc_number] => 08748394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Apo A-I mimetic peptides and methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 13/774464
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11160
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774464
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/774464 | Apo A-I mimetic peptides and methods of treatment | Feb 21, 2013 | Issued |
Array
(
[id] => 9427833
[patent_doc_number] => 08703910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Peptide toxin formulation'
[patent_app_type] => utility
[patent_app_number] => 13/768984
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13674
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768984
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768984 | Peptide toxin formulation | Feb 14, 2013 | Issued |
Array
(
[id] => 8829246
[patent_doc_number] => 20130130291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'Labelling of Fusion Proteins with Synthetic Probes'
[patent_app_type] => utility
[patent_app_number] => 13/755006
[patent_app_country] => US
[patent_app_date] => 2013-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9718
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13755006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/755006 | Labelling of Fusion Proteins with Synthetic Probes | Jan 30, 2013 | Abandoned |
Array
(
[id] => 10882276
[patent_doc_number] => 08906654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Kluyveromyces marxianus strains and method of using strains'
[patent_app_type] => utility
[patent_app_number] => 13/747691
[patent_app_country] => US
[patent_app_date] => 2013-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5908
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747691
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/747691 | Kluyveromyces marxianus strains and method of using strains | Jan 22, 2013 | Issued |
Array
(
[id] => 8940450
[patent_doc_number] => 20130190247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/737517
[patent_app_country] => US
[patent_app_date] => 2013-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10708
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13737517
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/737517 | PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME | Jan 8, 2013 | Abandoned |
Array
(
[id] => 8744558
[patent_doc_number] => 20130084274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'Liquid, Aqueous Pharmaceutical Compositions of Factor VII Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 13/685212
[patent_app_country] => US
[patent_app_date] => 2012-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16419
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13685212
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/685212 | Liquid, Aqueous Pharmaceutical Compositions of Factor VII Polypeptides | Nov 25, 2012 | Abandoned |
Array
(
[id] => 9463301
[patent_doc_number] => 20140127728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'REAGENT MATERIALS AND ASSOCIATED TEST ELEMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/667057
[patent_app_country] => US
[patent_app_date] => 2012-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15166
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13667057
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/667057 | Reagent materials and associated test elements | Nov 1, 2012 | Issued |